Montis Capital was among investors in Proteon Pharmaceuticals' EUR 21M financing round.
Proteon Pharmaceuticals focuses on sustainable protein production and develops bacteriophage solutions for dairy, aquaculture, and poultry to combat bacterial infections
Proteon Pharmaceuticals focuses on sustainable protein production and develops bacteriophage solutions for dairy, aquaculture, and poultry to combat bacterial infections.